{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:16:13Z","timestamp":1793632573204,"version":"4.5.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ningbo medical and health brand discipline","award":["PPXK2018-03"],"award-info":[{"award-number":["PPXK2018-03"]}]},{"name":"Ningbo medical and health brand discipline","award":["PPXK2018-03"],"award-info":[{"award-number":["PPXK2018-03"]}]},{"name":"Ningbo medical and health brand discipline","award":["PPXK2018-03"],"award-info":[{"award-number":["PPXK2018-03"]}]},{"name":"Ningbo medical and health brand discipline","award":["PPXK2018-03"],"award-info":[{"award-number":["PPXK2018-03"]}]},{"name":"Ningbo medical and health brand discipline","award":["PPXK2018-03"],"award-info":[{"award-number":["PPXK2018-03"]}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2022J262"],"award-info":[{"award-number":["2022J262"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2022J262"],"award-info":[{"award-number":["2022J262"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Municipal Key Technical Research and Development Program of Ningbo","award":["2023Z160"],"award-info":[{"award-number":["2023Z160"]}]},{"name":"Municipal Key Technical Research and Development Program of Ningbo","award":["2023Z160"],"award-info":[{"award-number":["2023Z160"]}]},{"name":"Municipal Key Technical Research and Development Program of Ningbo","award":["2023Z160"],"award-info":[{"award-number":["2023Z160"]}]},{"name":"Municipal Key Technical Research and Development Program of Ningbo","award":["2023Z160"],"award-info":[{"award-number":["2023Z160"]}]},{"name":"Lihuili Hospital Research and Cultivation Project","award":["2022KYPYXM-L2"],"award-info":[{"award-number":["2022KYPYXM-L2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backgroud<\/jats:title>\n                    <jats:p>We aimed to develop a novel preoperative nomogram to predict lymph node metastasis (LNM) in perihilar cholangiocarcinoma (pCCA) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>160 pCCA patients were enrolled at Lihuili Hospital from July 2006 to May 2022. A novel nomogram model was established to predict LNM in pCCA patients based on the independent predictive factors selected by the multivariate logistic regression model. The precision of the nomogram model was evaluated through internal and external validation with calibration curve statistics and the concordance index (C-index). Receiver operating characteristic (ROC) curve and decision curve analysis (DCA) were used to evaluate and determine the clinical utility of the nomogram.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Multivariate logistic regression demonstrated that age (\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20090.963, 95% CI: 0.930\u20130.996,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.030), CA19-9 level (&gt;\u2009559.8 U\/mL vs. \u2264559.8 U\/mL:\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20093.162, 95% CI: 1.519\u20136.582,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002) and tumour diameter (\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20091.388, 95% CI: 1.083\u20131.778,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.010) were independent predictive factors of LNM in pCCA patients. The C-index was 0.763 (95% CI: 0.667\u20130.860) and 0.677 (95% CI: 0.580\u20130.773) in training cohort and validation cohort, respectively. ROC curve analysis indicated the comparative stability and adequate discriminative ability of nomogram. The sensitivity and specificity were 0.820 and 0.652 in training cohort and 0.704 and 0.649 in validation cohort, respectively. DCA revealed that the nomogram model could augment net benefits in the prediction of LNM in pCCA patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The novel prediction model is useful for predicting LNM in pCCA patients and showed adequate discriminative ability and high predictive accuracy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-024-12068-1","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T14:02:27Z","timestamp":1709560947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Development and validation of a novel preoperative clinical model for predicting lymph node metastasis in perihilar cholangiocarcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Shuqi","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengdong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caide","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"issue":"9","key":"12068_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388. https:\/\/doi.org\/10.1038\/s41575-020-0310-z.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"12068_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer staging Manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139. https:\/\/doi.org\/10.3322\/caac.21388.","journal-title":"CA Cancer J Clin"},{"key":"12068_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0002-9343(65)90178-6","volume":"38","author":"G Klatskin","year":"1965","unstructured":"Klatskin G, Adenocarcinoma of the hepatic duct at its bifurcation within the Porta Hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med. 1965;38:241\u201356. https:\/\/doi.org\/10.1016\/0002-9343(65)90178-6.","journal-title":"Am J Med"},{"issue":"4","key":"12068_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1067\/msy.2002.127555","volume":"132","author":"A Nakeeb","year":"2002","unstructured":"Nakeeb A, Tran KQ, Black MJ, Erickson BA, Ritch PS, Quebbeman EJ, et al. Improved survival in resected biliary malignancies. Surgery. 2002;132(4):555\u201363. https:\/\/doi.org\/10.1067\/msy.2002.127555. discission 563\u2013\u2009554.","journal-title":"Surgery"},{"issue":"8","key":"12068_CR5","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1111\/liv.14856","volume":"41","author":"AM van Keulen","year":"2021","unstructured":"van Keulen AM, Franssen S, van der Geest LG, de Boer MT, Coenraad M, van Driel L, et al. Nationwide treatment and outcomes of perihilar cholangiocarcinoma. Liver Int. 2021;41(8):1945\u201353. https:\/\/doi.org\/10.1111\/liv.14856.","journal-title":"Liver Int"},{"issue":"4","key":"12068_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00534-009-0204-5","volume":"17","author":"SG Lee","year":"2010","unstructured":"Lee SG, Song GW, Hwang S, Ha TY, Moon DB, Jung DH, et al. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci. 2010;17(4):476\u201389. https:\/\/doi.org\/10.1007\/s00534-009-0204-5.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"9","key":"12068_CR7","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/annonc\/mdv279","volume":"26","author":"B Groot Koerkamp","year":"2015","unstructured":"Groot Koerkamp B, Wiggers JK, Gonen M, Doussot A, Allen PJ, Besselink MGH, et al. Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. Ann Oncol. 2015;26(9):1930\u20135. https:\/\/doi.org\/10.1093\/annonc\/mdv279.","journal-title":"Ann Oncol"},{"issue":"1","key":"12068_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","volume":"258","author":"M Nagino","year":"2013","unstructured":"Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258(1):129\u201340. https:\/\/doi.org\/10.1097\/SLA.0b013e3182708b57.","journal-title":"Ann Surg"},{"issue":"11","key":"12068_CR9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1445-2197.2005.03595.x","volume":"75","author":"EC Lai","year":"2005","unstructured":"Lai EC, Lau WY. Aggressive surgical resection for hilar cholangiocarcinoma. ANZ J Surg. 2005;75(11):981\u20135. https:\/\/doi.org\/10.1111\/j.1445-2197.2005.03595.x.","journal-title":"ANZ J Surg"},{"issue":"4","key":"12068_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/13651820500373010","volume":"7","author":"H Nishio","year":"2005","unstructured":"Nishio H, Nagino M, Nimura Y. Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB (Oxford). 2005;7(4):259\u201362. https:\/\/doi.org\/10.1080\/13651820500373010.","journal-title":"HPB (Oxford)"},{"issue":"5","key":"12068_CR11","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s11605-021-05211-x","volume":"26","author":"ZP Liu","year":"2022","unstructured":"Liu ZP, Zhang QY, Chen WY, Huang YY, Zhang YQ, Gong Y, et al. Evaluation of four Lymph Node classifications for the prediction of Survival in Hilar Cholangiocarcinoma. J Gastrointest Surg. 2022;26(5):1030\u201340. https:\/\/doi.org\/10.1007\/s11605-021-05211-x.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"12068_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000327361","volume":"28","author":"H Li","year":"2011","unstructured":"Li H, Qin Y, Cui Y, Chen H, Hao X, Li Q. Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience. Dig Surg. 2011;28(3):226\u201331. https:\/\/doi.org\/10.1159\/000327361.","journal-title":"Dig Surg"},{"issue":"19","key":"12068_CR13","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1002\/cncr.27492","volume":"118","author":"MC de Jong","year":"2012","unstructured":"de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, et al. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer. 2012;118(19):4737\u201347. https:\/\/doi.org\/10.1002\/cncr.27492.","journal-title":"Cancer"},{"issue":"1","key":"12068_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/bjs.6788","volume":"97","author":"A Kobayashi","year":"2010","unstructured":"Kobayashi A, Miwa S, Nakata T, Miyagawa S. Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg. 2010;97(1):56\u201364. https:\/\/doi.org\/10.1002\/bjs.6788.","journal-title":"Br J Surg"},{"issue":"6","key":"12068_CR15","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.jamcollsurg.2015.09.005","volume":"221","author":"B Groot Koerkamp","year":"2015","unstructured":"Groot Koerkamp B, Wiggers JK, Allen PJ, Besselink MG, Blumgart LH, Busch OR, et al. Recurrence rate and pattern of Perihilar Cholangiocarcinoma after curative intent resection. J Am Coll Surg. 2015;221(6):1041\u20139. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2015.09.005.","journal-title":"J Am Coll Surg"},{"issue":"4","key":"12068_CR16","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/SLA.0b013e3182822277","volume":"257","author":"T Aoba","year":"2013","unstructured":"Aoba T, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, et al. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg. 2013;257(4):718\u201325. https:\/\/doi.org\/10.1097\/SLA.0b013e3182822277.","journal-title":"Ann Surg"},{"issue":"10","key":"12068_CR17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1001\/jamasurg.2016.1769","volume":"151","author":"F Giuliante","year":"2016","unstructured":"Giuliante F, Ardito F, Guglielmi A, Aldrighetti L, Ferrero A, Calise F, et al. Association of Lymph Node Status with Survival in patients after Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis. JAMA Surg. 2016;151(10):916\u201322. https:\/\/doi.org\/10.1001\/jamasurg.2016.1769.","journal-title":"JAMA Surg"},{"issue":"2","key":"12068_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/jgh.13072","volume":"31","author":"K Mao","year":"2016","unstructured":"Mao K, Liu J, Sun J, Zhang J, Chen J, Pawlik TM, et al. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma. J Gastroenterol Hepatol. 2016;31(2):417\u201326. https:\/\/doi.org\/10.1111\/jgh.13072.","journal-title":"J Gastroenterol Hepatol"},{"issue":"16","key":"12068_CR19","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1200\/jco.2011.40.5381","volume":"30","author":"AM Horgan","year":"2012","unstructured":"Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012;30(16):1934\u201340. https:\/\/doi.org\/10.1200\/jco.2011.40.5381.","journal-title":"J Clin Oncol"},{"issue":"2","key":"12068_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ejso.2006.09.033","volume":"33","author":"Q Cheng","year":"2007","unstructured":"Cheng Q, Luo X, Zhang B, Jiang X, Yi B, Wu M. Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival. Eur J Surg Oncol. 2007;33(2):202\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2006.09.033.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"12068_CR21","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s00268-018-04883-y","volume":"43","author":"R Matsuyama","year":"2019","unstructured":"Matsuyama R, Morioka D, Mori R, Yabushita Y, Hiratani S, Ota Y, et al. Our rationale of initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: a proposal of Criteria for Borderline Resectable in the field of surgery for Hilar Cholangiocarcinoma. World J Surg. 2019;43(4):1094\u2013104. https:\/\/doi.org\/10.1007\/s00268-018-04883-y.","journal-title":"World J Surg"},{"issue":"4","key":"12068_CR22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s11605-023-05606-y","volume":"27","author":"A Parente","year":"2023","unstructured":"Parente A, Kamarajah SK, Baia M, Tirotta F, Manzia TM, Hilal MA, et al. Neoadjuvant Chemotherapy for Intrahepatic, Perihilar, and distal cholangiocarcinoma: a National Population-based comparative cohort study. J Gastrointest Surg. 2023;27(4):741\u20139. https:\/\/doi.org\/10.1007\/s11605-023-05606-y.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"12068_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12885-020-06895-1","volume":"20","author":"N Kuriyama","year":"2020","unstructured":"Kuriyama N, Usui M, Gyoten K, Hayasaki A, Fujii T, Iizawa Y, et al. Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status. BMC Cancer. 2020;20(1):405. https:\/\/doi.org\/10.1186\/s12885-020-06895-1.","journal-title":"BMC Cancer"},{"issue":"7","key":"12068_CR24","first-page":"1158","volume":"46","author":"MJ Reinhardt","year":"2005","unstructured":"Reinhardt MJ, Strunk H, Gerhardt T, Roedel R, Jaeger U, Bucerius J, et al. Detection of Klatskin\u2019s tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET\/CT: preliminary results for 22 patient studies. J Nucl Med. 2005;46(7):1158\u201363.","journal-title":"J Nucl Med"},{"issue":"6","key":"12068_CR25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/jso.21136","volume":"98","author":"J Li","year":"2008","unstructured":"Li J, Kuehl H, Grabellus F, M\u00fcller SP, Radunz S, Antoch G, et al. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET\/CT. J Surg Oncol. 2008;98(6):438\u201343. https:\/\/doi.org\/10.1002\/jso.21136.","journal-title":"J Surg Oncol"},{"issue":"35","key":"12068_CR26","doi-asserted-by":"publisher","first-page":"e20932","DOI":"10.1097\/md.0000000000020932","volume":"99","author":"X Huang","year":"2020","unstructured":"Huang X, Yang J, Li J, Xiong Y. Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography\/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: a meta-analysis. Med (Baltim). 2020;99(35):e20932. https:\/\/doi.org\/10.1097\/md.0000000000020932.","journal-title":"Med (Baltim)"},{"key":"12068_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.03.226","author":"S Faleh","year":"2023","unstructured":"Faleh S, Prakash I, Eisenberg E, Basik M, Boileau JF, Tejera D, et al. Predictors of nodal metastases in early stage HER2\u2009+\u2009breast cancer: deciding on treatment approach with neoadjuvant chemotherapy vs. upfront surgery. Eur J Surg Oncol. 2023. https:\/\/doi.org\/10.1016\/j.ejso.2023.03.226.","journal-title":"Eur J Surg Oncol"},{"key":"12068_CR28","doi-asserted-by":"publisher","first-page":"1062142","DOI":"10.3389\/fonc.2023.1062142","volume":"13","author":"J Li","year":"2023","unstructured":"Li J, Cui T, Huang Z, Mu Y, Yao Y, Xu W, et al. Analysis of risk factors for lymph node metastasis and prognosis study in patients with early gastric cancer: a SEER data-based study. Front Oncol. 2023;13:1062142. https:\/\/doi.org\/10.3389\/fonc.2023.1062142.","journal-title":"Front Oncol"},{"key":"12068_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/cmar.s344711","volume":"14","author":"H Zhao","year":"2022","unstructured":"Zhao H, Lu B. Prediction of multiple serum tumor markers in Hepatolithiasis complicated with Intrahepatic Cholangiocarcinoma. Cancer Manag Res. 2022;14:249\u201355. https:\/\/doi.org\/10.2147\/cmar.s344711.","journal-title":"Cancer Manag Res"},{"key":"12068_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cca.2022.09.012","volume":"536","author":"P Kimawaha","year":"2022","unstructured":"Kimawaha P, Thanan R, Jusakul A, Jamnongkan W, Silsirivanit A, Sa-Ngaimwibool P, et al. Serum \u03b12,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma. Clin Chim Acta. 2022;536:142\u201354. https:\/\/doi.org\/10.1016\/j.cca.2022.09.012.","journal-title":"Clin Chim Acta"},{"key":"12068_CR31","doi-asserted-by":"publisher","first-page":"721460","DOI":"10.3389\/fonc.2021.721460","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Shao J, Wang P, Chen L, Ying M, Chai S, et al. Deep Learning Radiomics to Predict Regional Lymph Node staging for Hilar Cholangiocarcinoma. Front Oncol. 2021;11:721460. https:\/\/doi.org\/10.3389\/fonc.2021.721460.","journal-title":"Front Oncol"},{"issue":"1","key":"12068_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1148\/radiol.2018181408","volume":"290","author":"GW Ji","year":"2019","unstructured":"Ji GW, Zhang YD, Zhang H, Zhu FP, Wang K, Xia YX, et al. Biliary Tract Cancer at CT: a Radiomics-based Model to Predict Lymph Node Metastasis and Survival outcomes. Radiology. 2019;290(1):90\u20138. https:\/\/doi.org\/10.1148\/radiol.2018181408.","journal-title":"Radiology"},{"issue":"1","key":"12068_CR33","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1186\/s12885-020-07501-0","volume":"20","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wu Z, Wang X, Li C, Chang J, Jiang W, et al. Development and external validation of a nomogram for predicting the effect of tumor size on survival of patients with perihilar cholangiocarcinoma. BMC Cancer. 2020;20(1):1044. https:\/\/doi.org\/10.1186\/s12885-020-07501-0.","journal-title":"BMC Cancer"},{"issue":"3","key":"12068_CR34","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3760\/cma.j.issn.0366-6999.20123235","volume":"127","author":"R Chen","year":"2014","unstructured":"Chen R, He Q, Cui J, Bian S, Chen L. Lymph node metastasis in early gastric cancer. Chin Med J (Engl). 2014;127(3):560\u20137.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"12068_CR35","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1186\/s12885-022-10436-3","volume":"22","author":"SK Geng","year":"2022","unstructured":"Geng SK, Fu SM, Zhang HW, Fu YP. Predictive nomogram based on serum tumor markers and clinicopathological features for stratifying lymph node metastasis in breast cancer. BMC Cancer. 2022;22(1):1328. https:\/\/doi.org\/10.1186\/s12885-022-10436-3.","journal-title":"BMC Cancer"},{"issue":"9","key":"12068_CR36","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/lary.29426","volume":"131","author":"DH Kim","year":"2021","unstructured":"Kim DH, Kim SW, Hwang SH. Predictive value of Delphian Lymph Node Metastasis in the thyroid Cancer. Laryngoscope. 2021;131(9):1990\u20136. https:\/\/doi.org\/10.1002\/lary.29426.","journal-title":"Laryngoscope"},{"key":"12068_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-022-10477-7","author":"H Rhee","year":"2023","unstructured":"Rhee H, Lim HJ, Han K, Yeom SK, Choi SH, Park JH, et al. A preoperative scoring system to predict lymph node metastasis in intrahepatic cholangiocarcinoma. Hepatol Int. 2023. https:\/\/doi.org\/10.1007\/s12072-022-10477-7.","journal-title":"Hepatol Int"},{"issue":"7","key":"12068_CR38","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1007\/s00330-019-06142-7","volume":"29","author":"GW Ji","year":"2019","unstructured":"Ji GW, Zhu FP, Zhang YD, Liu XS, Wu FY, Wang K, et al. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma. Eur Radiol. 2019;29(7):3725\u201335. https:\/\/doi.org\/10.1007\/s00330-019-06142-7.","journal-title":"Eur Radiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12068-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T14:03:05Z","timestamp":1709560985000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12068-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12068"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12068-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"22 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is in accordance with the Declaration of Helsinki and has been approved by the ethical committee of Ningbo Medical Center Lihuili Hospital, Ningbo University. The study is retrospective cohort study and only clinical information of patients will be collected without interfering with patients\u2019 treatment plans or posing physiological risks to patients. All research procedures were in compliance with the relevant guideline and regulations. Informed consent was obtained from all patients prior to being included.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"297"}}